NCT02724098View on ClinicalTrials.gov

Bioavailability of Subcutaneous Dexmedetomidine

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2017

Conditions
Pain
Interventions
DRUG

Dexmedetomidine

Trial Locations (1)

20521

Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT02724098 - Bioavailability of Subcutaneous Dexmedetomidine | Biotech Hunter | Biotech Hunter